Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment

被引：113
作者：
Roden, Dan M. [1 ]
Harrington, Robert A. [2 ]
Poppas, Athena [3 ]
Russo, Andrea M. [4 ,5 ]
机构：
[1] Vanderbilt Univ, Sch Med, Div Cardiovasc Med & Clin Pharmacol, Nashville, TN 37232 USA
[2] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[3] Brown Univ, Sch Med, Cardiol Div, Providence, RI 02912 USA
[4] Cooper Univ Hosp, Electrophysiol & Arrhythmia Serv, Camden, NJ USA
[5] Rowan Univ, Cooper Med Sch, Clin Cardiac Electrophysiol Fellowship Program, Camden, NJ USA
来源：
CIRCULATION | 2020年 / 141卷 / 24期
关键词：
arrhythmias; cardiac; COVID-19; drug effects; drug-related side effects and adverse reactions; severe acute respiratory syndrome coronavirus 2; INTERVAL PROLONGATION; AZITHROMYCIN; RISKS;
D O I：
10.1161/CIRCULATIONAHA.120.047521
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E906 / E907
页数：2
相关论文
共 50 条
  • [21] Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
    Angel Martinez, Miguel
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
  • [22] Teicoplanin: an alternative drug for the treatment of COVID-19?
    Baron, Sophie Alexandra
    Devaux, Christian
    Colson, Philippe
    Raoult, Didier
    Rolain, Jean-Marc
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (04)
  • [23] Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
    Devaux, Christian A.
    Melenotte, Clea
    Piercecchi-Marti, Marie-Dominique
    Delteil, Clemence
    Raoult, Didier
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [24] POTENTIAL DRUG-DRUG INTERACTIONS IN HOSPITALIZED PATIENTS WITH COVID-19
    Szkutnik-Fiedler, Danuta
    Kwiatkowski, Filip
    Chomej, Monika
    Kolodziej, Dorota
    Michalak, Michal
    Grzeskowiak, Edmund
    Szalek, Edyta
    [J]. ACTA POLONIAE PHARMACEUTICA, 2023, 80 (02): : 277 - 287
  • [25] Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
    Dhameliya, Hiren A.
    Thakkar, Vasudev R.
    Trivedi, Gauravi N.
    Mesara, Sureshkumar N.
    Subramanian, R. B.
    [J]. JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2020, 14 : 861 - 867
  • [26] POTENTIAL DRUG CANDIDATES FOR TREATMENT OF COVID-19
    Kumudhaveni, B.
    Kathirvel, S.
    Muthu, S. Deepak
    Jeradsuresh, A.
    Radha, R.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (09): : 4087 - 4094
  • [27] Sitagliptin: a potential drug for the treatment of COVID-19?
    Bardaweel, Sanaa K.
    Hajjo, Rima
    Sabbah, Dima A.
    [J]. ACTA PHARMACEUTICA, 2021, 71 (02) : 175 - 184
  • [28] Considerations of COVID-19 in Ophthalmology
    Salvetat, Maria Letizia
    Musa, Mutali
    Pellegrini, Francesco
    Salati, Carlo
    Spadea, Leopoldo
    Zeppieri, Marco
    [J]. MICROORGANISMS, 2023, 11 (09)
  • [29] QTc interval and electrocardiographic findings of COVID-19 patients Electrocardiographic findings of COVID-19 patients
    Ay, Mehmet Oguzhan
    Kozaci, Nalan
    Ay, Ozlem Oymak
    Kaya, Halil
    Bulut, Mehtap
    Yuksel, Melih
    Adali, Ebru
    Kenan, Enad
    Cetin, Ebru
    [J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 (09): : 1031 - 1036
  • [30] Coronavirus disease 2019 (COVID-19) and QTc prolongation
    Khalid Changal
    David Paternite
    Sean Mack
    Spiro Veria
    Rehana Bashir
    Mitra Patel
    Ronak Soni
    Muhammad Ali
    Tanveer Mir
    Mujeeb Sheikh
    P. Kasi Ramanathan
    [J]. BMC Cardiovascular Disorders, 21
12345